WCNC Charlotte talks with a bariatric surgeon about why the drug nicknamed RETA is drawing attention even though it has no FDA approval.
Recap by typeshit. Post by WCNC Charlotte on X.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
A piece on questions about tirzepatide and breast cancer risk. Only the headline is available, so check the source for what the evidence says.
Tirzepatide alone reached 14.8% in the same trial. The catch: up to 27% of people on the combination quit over side effects, per the Motley Fool writeup.
Bloomberg Law reports Lilly has widened its legal push against sellers of knockoff versions of its experimental obesity drug, which is still unapproved.
Loading…